Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate

Eugene S. Flamm, J. Ransohoff

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Twelve patients with cerebral vasospasm following subarachnoid hemorrhage were treated with intravenous aminophylline and isoproterenol. After angiographic demonstration of spasm, all patients were begun on a continuous intravenous infusion of isoproterenol, 125 μg/hr, and aminophylline, 125 mg/hr, for a period of up to two weeks. The infusion was continued until there was clinical or angiographic evidence that spasm had diminished. Nine patients improved on this regimen and three remained unchanged. The use of isoproterenol and aminophylline is based on their effect on the enzymes responsible for the formation and degradation of cyclic adenosine monophosphate (cyclic AMP). An increase in cyclic AMP has been noted to produce relaxation of vascular smooth muscle. It is proposed that manipulation of these biochemical pathways may provide a method for influencing blood flow through cerebral vessels.

Original languageEnglish (US)
Pages (from-to)223-226
Number of pages4
JournalSurgical Neurology
Volume6
Issue number4
StatePublished - 1976
Externally publishedYes

Fingerprint

Intracranial Vasospasm
Aminophylline
Isoproterenol
Cyclic AMP
Spasm
Cerebrovascular Circulation
Subarachnoid Hemorrhage
Vascular Smooth Muscle
Intravenous Infusions
Therapeutics
Enzymes

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate. / Flamm, Eugene S.; Ransohoff, J.

In: Surgical Neurology, Vol. 6, No. 4, 1976, p. 223-226.

Research output: Contribution to journalArticle

@article{871394dab1af4fad8cc0563437b8cee7,
title = "Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate",
abstract = "Twelve patients with cerebral vasospasm following subarachnoid hemorrhage were treated with intravenous aminophylline and isoproterenol. After angiographic demonstration of spasm, all patients were begun on a continuous intravenous infusion of isoproterenol, 125 μg/hr, and aminophylline, 125 mg/hr, for a period of up to two weeks. The infusion was continued until there was clinical or angiographic evidence that spasm had diminished. Nine patients improved on this regimen and three remained unchanged. The use of isoproterenol and aminophylline is based on their effect on the enzymes responsible for the formation and degradation of cyclic adenosine monophosphate (cyclic AMP). An increase in cyclic AMP has been noted to produce relaxation of vascular smooth muscle. It is proposed that manipulation of these biochemical pathways may provide a method for influencing blood flow through cerebral vessels.",
author = "Flamm, {Eugene S.} and J. Ransohoff",
year = "1976",
language = "English (US)",
volume = "6",
pages = "223--226",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate

AU - Flamm, Eugene S.

AU - Ransohoff, J.

PY - 1976

Y1 - 1976

N2 - Twelve patients with cerebral vasospasm following subarachnoid hemorrhage were treated with intravenous aminophylline and isoproterenol. After angiographic demonstration of spasm, all patients were begun on a continuous intravenous infusion of isoproterenol, 125 μg/hr, and aminophylline, 125 mg/hr, for a period of up to two weeks. The infusion was continued until there was clinical or angiographic evidence that spasm had diminished. Nine patients improved on this regimen and three remained unchanged. The use of isoproterenol and aminophylline is based on their effect on the enzymes responsible for the formation and degradation of cyclic adenosine monophosphate (cyclic AMP). An increase in cyclic AMP has been noted to produce relaxation of vascular smooth muscle. It is proposed that manipulation of these biochemical pathways may provide a method for influencing blood flow through cerebral vessels.

AB - Twelve patients with cerebral vasospasm following subarachnoid hemorrhage were treated with intravenous aminophylline and isoproterenol. After angiographic demonstration of spasm, all patients were begun on a continuous intravenous infusion of isoproterenol, 125 μg/hr, and aminophylline, 125 mg/hr, for a period of up to two weeks. The infusion was continued until there was clinical or angiographic evidence that spasm had diminished. Nine patients improved on this regimen and three remained unchanged. The use of isoproterenol and aminophylline is based on their effect on the enzymes responsible for the formation and degradation of cyclic adenosine monophosphate (cyclic AMP). An increase in cyclic AMP has been noted to produce relaxation of vascular smooth muscle. It is proposed that manipulation of these biochemical pathways may provide a method for influencing blood flow through cerebral vessels.

UR - http://www.scopus.com/inward/record.url?scp=0017149993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017149993&partnerID=8YFLogxK

M3 - Article

C2 - 184555

AN - SCOPUS:0017149993

VL - 6

SP - 223

EP - 226

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 4

ER -